Publications
- Severe secondary immune thrombocytopenia in a patient with chronic lymphocytic leukemia2022 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO-CLLEAR Study by the Czech CLL Study Group2020 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status2017 | Faculty of Medicine in Hradec Králové
- Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia2016 | Faculty of Medicine in Hradec Králové
- Venous thromboembolism in patients with chronic lymphocytic leukemia2015 | Faculty of Medicine in Hradec Králové
- Prognostic relevance of angiopoietin-2, fibroblast growth factor-2 and endoglin mRNA expressions in chronic lymphocytic leukemia2014 | Faculty of Medicine in Hradec Králové
- Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features2010 | Faculty of Medicine in Hradec Králové
- Significant change in ZAP-70 expression during the course of chronic lymphocytic leukemia2010 | Faculty of Medicine in Hradec Králové
- Biological prognostic markers in chronic lymphocytic leukemia +12009 | Faculty of Medicine in Hradec Králové
- Biological prognostic markers in chronic lymphocytic leukemia2009 | First Faculty of Medicine
Loading network view...